Zuletzt aktualisiert: June 18, 2026

Mechanismus-Haftungsausschluss

Die Diskussion biologischer Mechanismen impliziert keine therapeutische Wirksamkeit außerhalb FDA-zugelassener Kontexte.

Das Komplementsystem ist eine zentrale Komponente der angeborenen Immunabwehr — eine Kaskade von mehr als 30 Plasma- und Membranproteinen, die Pathogene markieren und zerstören. Medizinische Blutegel haben spezifische Inhibitoren entwickelt, die auf wichtige Komplementkomponenten abzielen, was ihre fortgesetzte Blutfütterung ermöglicht, ohne komplementvermittelte Immunabwehrreaktionen auszulösen.

C1s-Inhibitor-Eigenschaften

Molekulare Eigenschaften

The C1s inhibitor is a 67 kDa single-chain Protein — substantially larger than most leech Proteinase inhibitors. Its size places it in a distinct structural category from the small-molecule inhibitors (hirudin, eglins, LDTI) that dominate the SDS Proteom.

Wirkmechanismus

The inhibitor blocks C4 activation by C1s, thereby preventing formation of the C3 convertase (C4b2a) — the central amplification Enzym of the classical pathway. Without C3 convertase, the downstream cascade (C3b opsonization, C5a chemotaxis, C5b-9 membrane attack complex) is halted.

Übersicht Komplementsystem

Classical Pathway — Point of SDS Inhibition

C1-Komplex

C1q + C1r + C1s

Antikörper-Antigen-Erkennung

C1s-Aktivierung

Spaltet C4 → C4a + C4b

SDS BLOCKIERT HIER

C3-Konvertase

C4b2a-Komplex

Amplifikationsschritt

Terminal Pathway

C5b-9 MAK

Zelllyse

Biologische Funktion

Leech Self-Protection

During Blutfütterung, der Blutegel is exposed to the Wirts-complement system. The C1s inhibitor protects leech tissues at the Bissstelle from complement-mediated damage. This is particularly critical during the 20–45 minute feeding period when leech jaw tissue is in direct contact with host blood.

Schutz durch Aeromonas-Symbionten

Der Blutegel obligate symbiotic Bakterium Aeromonas veronii is Gram-negative and vulnerable to complement-mediated lysis. The C1s inhibitor helps protect these symbionts während des Fressens. Additionally, Aeromonas produces its own complement resistance via a 52 kDa S-layer Protein that confers resistance to the membrane attack complex.

Duale Pfad-Hemmung

Classical and Alternative Pathway Blockade (Baskova et al., 1988)

Baskova et al. (1988) demonstrated that Blutegel-SDS inhibits sowohl the classical pathway (C1s-dependent, antibody-mediated) and the alternative pathway (factor B/D-dependent, spontaneous activation). This dual inhibition suggests entweder zusätzlich complement inhibitory molecules beyond the C1s inhibitor, or that downstream targets (such as C3 convertase components shared by sowohl pathways) are also affected. The thorough anticomplementary activity ensures der Blutegel can feed on hosts regardless of their complement activation status.

Therapeutic Context

Hereditäres Angioödem (HAE)

HAE is caused by deficiency or dysfunction of human C1 inhibitor (C1-INH), affecting approximately 1 in 50,000 individuals. Uncontrolled C1s activity leads to excessive bradykinin production and severe, potenziellly fatal angioedema. FDA-zugelassenen C1 inhibitor replacement therapies include Cinryze (IV, prophylaxis) and Berinert (IV, acute attacks), validating C1 pathway modulation as a therapeutic strategy.

Piyavit Anticomplementary Activity

Piyavit, a pharmaceutical formulation derived from whole Blutegelextrakt (Chapter 18), demonstrates measurable anticomplementary activity. The C1s inhibitor is a likely contributor to this effect. The anticomplementary properties of Piyavit are considered part of its broader immunomodulatory profile, alongside anti-inflammatory and antithrombotic activities.

Evolutionäre Bedeutung

Complement inhibition represents a critical evolutionäre Anpassung for obligate blutfressend organisms. Der Blutegel deploys a multi-layered strategy: a dedicated C1s inhibitor in SDS for immediate host complement suppression, combined with Aeromonas S-layer Protein for symbiont-level protection. This dual-organism defense system ensures successful Blutfütterung and subsequent digestion — a co-evolved partnership between metazoan host and bakteriell symbiont that wurde refined over millions of years of hematophagous specialization.

Komplement-Inhibitoren